EyePoint Pharmaceuticals, Inc., a specialty biopharma company developing ophthalmic products, has appointed George O. Elston as chief financial officer and head of corporate development. Mr. Elston has previously been a consultant to the company and will now lead the company’s financial, capital markets, and corporate development initiatives. Mr. Elston brings more than 25 years of diverse financial and senior leadership experience in the biopharmaceutical sector with both global publicly-traded...